Jay Schnitzer Email Address

Senior Vice President, Chief Technology Officer

systems engineering

PROFESSIONAL ACCOMPLISHMENTS Oversees medical and health related work at MITRE, and co-chaired the COVID-19 Healthcare Coalition, https://c19hcc.org. Created two signature “moonshots” – 1) the Oncology – Standard Health Record moonshot to use electronic clinical data to derive clinical trial endpoints, and 2) the Quantum Information Science (QIS) moonshot to create major advances in quantum computing, sensing, and communications based solely on photons as quantum bits. Continue to oversee and direct these two major high technical risk efforts. Co-led an assessment of NOAA scientific integrity policies and procedures as applied to Karl T, et al.: Possible Artifacts of Data Biases in the Recent Global Surface Warming Hiatus. Science, 2015. Redesigned the MITRE R&D program to maximize impact to US government and the nation. Led writing and editing of Integrated Report for Independent Assessment performed in response to Section 201 of Veterans Choice Act. Organized and facilitated Blue Ribbon Panel. Led greenspace development of new health FFRDC. Expanded portfolio of new programs and increased annual budget of the Defense Sciences Office (DSO) at DARPA from $350 to 460 million and improved team morale in 14 months (usually requires 3-4 years). Led creation of new clinical-medical team spanning 4 divisions of an $8 billion global medical device company with 25,000 employees resulting in execution of state-of-the-art best practices for medical device development and distribution based on rigorous clinical data. Provided medical and clinical leadership that supported the successful sale of a $1 billion medical device division. Led NIH-funded research effort demonstrating efficacy of glucocorticoids in accelerating maturity and antioxidants in stimulating growth of hypoplastic lungs in congenital diaphragmatic hernia (CDH). Research led to a subsequent multimillion dollar NIH program investigating the genetics of CDH globally to influence future strategies towards targeted therapeutics. Co-invented intratracheal pulmonary ventilator (ITPV) that had the potential to support tiny, fragile lungs gently, preventing baro- and volu-trauma, thereby improving survival, potentially by as much as 50%. Supervised a 6 member medical response team at Ground Zero for 2 weeks following 9-11, treating FDNY, NYPD, and Iron workers resulting in their ability to conduct continuous uninterrupted 24 hour search and rescue operations for two weeks following the destruction of the twin towers.